These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15217960)

  • 1. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms.
    Socinski MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4210s-4214s. PubMed ID: 15217960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in metastatic and locally advanced non-small cell lung cancer.
    Spigel DR; Greco FA
    Semin Surg Oncol; 2003; 21(2):98-110. PubMed ID: 14508860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future beyond platinum for the treatment of advanced non-small cell lung cancer.
    Dragnev KH; Rigas JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):73-6. PubMed ID: 10585012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.
    Lilenbaum RC; List M; Desch C
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):52-4. PubMed ID: 10566612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.
    D'Addario G; Pintilie M; Leighl NB; Feld R; Cerny T; Shepherd FA
    J Clin Oncol; 2005 May; 23(13):2926-36. PubMed ID: 15728229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on North American randomized studies in non-small cell lung cancer.
    Bunn PA; Vokes EE; Langer CJ; Schiller JH
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):2-10. PubMed ID: 9728578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line combination chemotherapy for advanced non-small cell lung cancer: the Eastern Cooperative Oncology Group and Southwest Oncology Group experience.
    Sandler A
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):44-51. PubMed ID: 10566611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
    Bunn PA
    Anticancer Drugs; 2001 Jul; 12 Suppl 3():S3-8. PubMed ID: 11556251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in chemotherapy for advanced non-small cell lung cancer.
    Raez LE; Lilenbaum R
    Curr Opin Oncol; 2006 Mar; 18(2):156-61. PubMed ID: 16462185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation paradigm for the treatment of lung cancer.
    Eberhardt W; Pöttgen C; Stuschke M
    Nat Clin Pract Oncol; 2006 Apr; 3(4):188-99. PubMed ID: 16596143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin doublets in non-small cell lung cancer: a literature review.
    Cortinovis D; Bidoli P; Zilembo N; Fusi A; Bajetta E
    Lung Cancer; 2008 Jun; 60(3):325-31. PubMed ID: 18440088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced non-small cell lung cancer.
    Shepherd FA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):7-18. PubMed ID: 8091244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.